Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.0 - $0.01 $0 - $1,501
-150,150 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.77 - $11.33 $866,365 - $1.7 Million
150,150 New
150,150 $1.37 Million

Others Institutions Holding KLDO

# of Institutions
1
Shares Held
2.3K
Call Options Held
0
Put Options Held
0

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Trustees Of Columbia University In The City Of New York Portfolio

Follow Trustees Of Columbia University In The City Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Columbia University In The City Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Columbia University In The City Of New York with notifications on news.